These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12498970)
21. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis. Kim J; Eltorai AE; Jiang H; Liao F; Verghese PB; Kim J; Stewart FR; Basak JM; Holtzman DM J Exp Med; 2012 Nov; 209(12):2149-56. PubMed ID: 23129750 [TBL] [Abstract][Full Text] [Related]
22. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells. Mazur-Kolecka B; Frackowiak J; Wiśniewski HM Brain Res; 1995 Nov; 698(1-2):217-22. PubMed ID: 8581485 [TBL] [Abstract][Full Text] [Related]
23. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Sato M; Doi H; Kurabayashi M Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1384-90. PubMed ID: 15217807 [TBL] [Abstract][Full Text] [Related]
24. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition? Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195 [TBL] [Abstract][Full Text] [Related]
25. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417 [TBL] [Abstract][Full Text] [Related]
26. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier. Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854 [TBL] [Abstract][Full Text] [Related]
27. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
28. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice. Frackowiak J; Miller DL; Potempska A; Sukontasup T; Mazur-Kolecka B J Neuropathol Exp Neurol; 2003 Jun; 62(6):685-96. PubMed ID: 12834113 [TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Poirier J Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807 [TBL] [Abstract][Full Text] [Related]
30. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Van Nostrand WE; Davis-Salinas J; Saporito-Irwin SM Ann N Y Acad Sci; 1996 Jan; 777():297-302. PubMed ID: 8624102 [TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice. Irizarry MC; Cheung BS; Rebeck GW; Paul SM; Bales KR; Hyman BT Acta Neuropathol; 2000 Nov; 100(5):451-8. PubMed ID: 11045665 [TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Prior R; Wihl G; Urmoneit B Ann N Y Acad Sci; 2000 Apr; 903():180-6. PubMed ID: 10818506 [TBL] [Abstract][Full Text] [Related]
34. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
35. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430 [TBL] [Abstract][Full Text] [Related]
36. Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis. Mattsson N; Insel PS; Palmqvist S; Stomrud E; van Westen D; Minthon L; Zetterberg H; Blennow K; Hansson O Nat Commun; 2016 Mar; 7():10918. PubMed ID: 26948379 [TBL] [Abstract][Full Text] [Related]
37. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity. Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204 [TBL] [Abstract][Full Text] [Related]
38. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. Keeney JT; Ibrahimi S; Zhao L J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005 [TBL] [Abstract][Full Text] [Related]
39. Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta. Uribe-San Martín R; Herrera-Molina R; Olavarría L; Ramírez G; von Bernhardi R Neuroscience; 2009 Feb; 158(4):1338-47. PubMed ID: 19041694 [TBL] [Abstract][Full Text] [Related]
40. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]